Drawing for NORTHERN ADJUVANTS

USPTO serial 79407682

NORTHERN ADJUVANTS

Reviewed by CopyMark Law Group

Reg. 7943132Status 700Registered
Filing date
Status date
Registration date
Sep 16, 2025
Examiner
O'BRIEN, JENNIFER LYNN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NORTHERN ADJUVANTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson Street, NWSuite 400Washington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry with exception of manures, except fungicides, herbicides, insecticides and parasiticides; chemical auxiliaries and intermediate products for the manufacture of pharmaceutical and cosmetic products; unprocessed artificial resins, unprocessed plastics; unprocessed artificial resins in the form of powders, granules, solutions, emulsions, dispersions, and pastes, in particular for use as auxiliaries for the manufacture of pharmaceutical products; unprocessed biodegradable polymers for medical and pharmaceutical use; unprocessed acrylic polymers for medical and pharmaceutical use; polymethyl methacrylate in the nature of unprocessed polymethyl methacrylate resins; lactic acid, namely, lactides for industrial purposes, lactides for use in pharmaceuticals, lactides for use in manufacture, lactides for use in the manufacture of pharmaceutical products; glycol, namely, glycolides for industrial purposes, glycolides for use in pharmaceuticals, glycolides for use in manufacture, glycolides for use in the manufacture of pharmaceutical products; industrial chemicals, namely, dioxanones; trimethylene carbonates; industrial chemicals, namely, caprolactones; chemical substances for preserving foodstuffs; adhesives used in industry.ACTIVE—
005Pharmaceutical and veterinary preparations, namely, adjuvants for medical and veterinary purposes; adjuvants for medical purposes; Drug delivery agents in the form of coatings, lacquers and glazes: Drug delivery agents in the form of coatings, lacquers and glazes that facilitate the delivery of pharmaceutical preparations and veterinary preparations as well as for dietetic substances; cellulose esters for pharmaceutical purposes; diagnostic preparations for medical purposes; capsules for medical purposes, sold empty for pharmaceuticals; Pharmaceutical and veterinary preparations, namely, Diagnostic media for bacteriological cultures, Diagnostic biomarker reagents for medical purposes, Diagnostic reagents and contrast media for medical use; dietetic preparations adapted for medical purposes and nutritional supplements; dietetic substances adapted for medical use, namely, Dietetic preparations adapted for medical purposes, Dietetic foods adapted for medical useACTIVE—
040Treatment of materials, namely processing of chemical and pharmaceutical polymers for the manufacture of chemical, pharmaceutical and veterinary preparations; custom manufacture of chemical, pharmaceutical and veterinary products by means of microencapsulating techniques for others; treatment of materials, namely processing of biodegradable polymers for medical applications, in particular tissue replacement, bone formation and bone fixation as well as for the manufacture of chemical, pharmaceutical and veterinary preparations; treatment of materials, namely processing of chemical and pharmaceutical preparations for the controlled release of active ingredients in chemical, pharmaceutical and veterinary preparations; treatment of materials, namely processing of chemical and pharmaceutical preparations used for surgical, medical, dental and veterinary apparatus and instruments as well as diagnostic apparatus for medical use and apparatus for use in medical analysis; treatment of materials, namely processing of biodegradable polymers for the manufacture of artificial limbs, artificial implants, stents, syringes for medical purposes, catheter, cannula, acupuncture needles, suture needles, artificial limbs, eyes and teeth, medical guidewires, orthopedic articles, suture materials.ACTIVE—
042Scientific and technological services, namely, scientific research, analysis and testing in the field of medical, veterinary, pharmaceutical, nutrition, and dietary products; product research and design relating thereto; industrial analysis and research services in the field of scientific chemicals and chemistry; design and development of computer hardware and software; technological research in the field of manufacturing, namely, technical consultancy in the field of the manufacture of chemical, pharmaceutical and veterinary preparations using chemical and pharmaceutical polymers; technical product development consultancy in the field of the use of biodegradable polymers for medical applications; quality control for others and material testing; expert opinion relating to technology, namely, technology consultation in the field of scientific research; materials testing and analysis; chemistry services, namely, professional consulting services and advice about agricultural chemistry, research in the field of chemistry and chemistry consultation; engineering services, engineering design services and chemical engineering services; engineering design services; bacteriological or chemical laboratory research services; physics research.ACTIVE—
044Medical services; veterinary services; consultancy and information services in the field of manufacture of pharmaceuticals, namely relating to pharmaceutical compounding services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 16, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 9, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 28, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 28, 2026FIMPFINAL DISPOSITION PROCESSED—
Mar 23, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 23, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 16, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 16, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 16, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 29, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 29, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 23, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 20, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 17, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 2, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 11, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 11, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 23, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 22, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2025DOCKASSIGNED TO EXAMINER—
Oct 27, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 27, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance